Xponance’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $145K | Buy |
+10,352
| New | +$145K | ﹤0.01% | 1369 |
|
|
2024
Q4 | – | Sell |
-8,135
| Closed | -$237K | – | 1451 |
|
|
2024
Q3 | $237K | Buy |
+8,135
| New | +$237K | ﹤0.01% | 1163 |
|
|
2023
Q3 | – | Sell |
-6,963
| Closed | -$205K | – | 1251 |
|
|
2023
Q2 | $205K | Buy |
+6,963
| New | +$205K | ﹤0.01% | 1143 |
|
|
2021
Q4 | – | Sell |
-4,315
| Closed | -$218K | – | 1179 |
|
|
2021
Q3 | $218K | Sell |
4,315
-699
| -14% | -$35.3K | ﹤0.01% | 1102 |
|
|
2021
Q2 | $393K | Buy |
+5,014
| New | +$393K | 0.01% | 1003 |
|